While using genetics to inform schizophrenia management has become a promising new method, it also comes with several ethical challenges. Dr. Aaron Besterman, a Health Sciences Associate Clinical Professor at UC San Diego, explains how limited research and potential risks can complicate how we leverage these genetic technologies.
